Overview

Dose-ranging Study of SKF7™ for Obesity

Status:
Completed
Trial end date:
2021-05-22
Target enrollment:
Participant gender:
Summary
This study has been designed as a randomized, double blinded, multi-centric, placebo controlled, and phase II dose-ranging study. The herbal drug contains bioactive ingredients from Labisia pumila plant and it is an aqueous ethanolic standardized extract (SKF7™).
Phase:
Phase 2
Details
Lead Sponsor:
Indonesia University
Collaborator:
Medika Natura Sdn Bhd